Dupilumab

From WikiMD.org
Jump to navigation Jump to search

Dupilumab (pronounced doo-pil-yoo-mab) is a type of biologic therapy used in the treatment of certain autoimmune diseases.

Etymology

The name "Dupilumab" is derived from the combination of "du" (meaning two in French), "pilus" (Latin for hair, referring to the two pronged approach of the drug), and "mab" (an abbreviation for monoclonal antibody).

Usage

Dupilumab is primarily used in the treatment of atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. It works by blocking the action of two proteins, interleukin-4 and interleukin-13, which are known to play a key role in the inflammatory response that occurs in these conditions.

Administration

Dupilumab is administered by subcutaneous injection, usually given every two weeks. The dosage may vary depending on the specific condition being treated and the patient's overall health status.

Side Effects

Common side effects of Dupilumab include redness, itching, and swelling at the injection site. Other potential side effects include conjunctivitis, headache, and cold sores in the mouth or on the lips.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski